Unknown

Dataset Information

0

Adamantyl ethanone pyridyl derivatives: potent and selective inhibitors of human 11?-hydroxysteroid dehydrogenase type?1.


ABSTRACT: Elevated levels of active glucocorticoids have been implicated in the development of several phenotypes of metabolic syndrome, such as type?2 diabetes and obesity. 11?-Hydroxysteroid dehydrogenase type?1 (11?-HSD1) catalyses the intracellular conversion of inactive cortisone to cortisol. Selective 11?-HSD1 inhibitors have shown beneficial effects in various conditions, including diabetes, dyslipidemia and obesity. A series of adamantyl ethanone pyridyl derivatives has been identified, providing potent and selective inhibitors of human 11?-HSD1. Lead compounds display low nanomolar inhibition against human and mouse 11?-HSD1 and are selective for this isoform, with no activity against 11?-HSD2 and 17?-HSD1. Structure-activity relationship studies reveal that an unsubstituted pyridine tethered to an adamantyl ethanone motif through an ether or sulfoxide linker provides a suitable pharmacophore for activity. The most potent inhibitors have IC?? values around 34-48?nM against human 11?-HSD1, display reasonable metabolic stability in human liver microsomes, and weak inhibition of key human CYP450 enzymes.

SUBMITTER: Su X 

PROVIDER: S-EPMC3179844 | biostudies-literature | 2011 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Adamantyl ethanone pyridyl derivatives: potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1.

Su Xiangdong X   Pradaux-Caggiano Fabienne F   Vicker Nigel N   Thomas Mark P MP   Halem Heather H   Culler Michael D MD   Potter Barry V L BV  

ChemMedChem 20110628 9


Elevated levels of active glucocorticoids have been implicated in the development of several phenotypes of metabolic syndrome, such as type 2 diabetes and obesity. 11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) catalyses the intracellular conversion of inactive cortisone to cortisol. Selective 11β-HSD1 inhibitors have shown beneficial effects in various conditions, including diabetes, dyslipidemia and obesity. A series of adamantyl ethanone pyridyl derivatives has been identified, providing  ...[more]

Similar Datasets

| S-EPMC3170876 | biostudies-literature
| S-EPMC3510433 | biostudies-literature
| S-EPMC9492458 | biostudies-literature
| S-EPMC4094253 | biostudies-literature
| S-EPMC8659031 | biostudies-literature
| S-EPMC3880318 | biostudies-literature
| S-EPMC6099733 | biostudies-literature
| S-EPMC5107914 | biostudies-literature
| S-EPMC9154221 | biostudies-literature
| S-EPMC5418052 | biostudies-literature